The Diabetes Research Institute (DRI), a Center of Excellence at the University of Miami Miller School of Medicine, announced today that the first patient in its clinical trial to test for the first time a novel transplant technique for insulin-producing cells was successfully completed. This FDA-approved Phase I/II study builds upon decades of progress in clinical islet transplantation and is an important first step toward the development of the DRI BioHub, a bioengineered mini organ that will mimic the native pancreas to restore natural insulin production in people with type 1 diabetes.
“This was the first transplant of islets on the surface of the omentum, a highly vascularized tissue covering abdominal organs, using a biologic, fully re-absorbable scaffold technique,” said Camillo Ricordi, M.D., Director of the DRI and the Stacy Joy Goodman Professor of Surgery, Distinguished Professor of Medicine, Professor of Biomedical Engineering, Microbiology and Immunology. Dr. Ricordi also serves as director of the DRI’s Cell Transplant Center. “The site is easily accessed by minimally invasive surgery, and more importantly, has the same blood supply and drainage characteristics of the pancreas — where islets are originally found before they are destroyed in type 1 diabetes.”
Omaida C. Velazquez, M.D., professor of surgery, radiology, and biochemistry and molecular biology, and David Kimmelman Endowed Chair in Vascular and Endovascular Surgery, has been named Chair of the DeWitt Daughtry Family Department of Surgery at the University of Miami Miller School of Medicine, after a thorough search that reviewed the most talented leaders in the surgical field in the U.S.
“Done.” When he uttered that single word at the University of Miami Leonard M. Miller School of Medicine’s May 9 commencement ceremony, Stuart Miller, chair of UM’s Momentum2Medical campaign, helped carry the school past its $1 billion fundraising goal.
A genetics researcher at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has contributed to a multi-center study linking a molecular factor with the body’s inflammatory response.
The University of Miami Miller School of Medicine is part of a statewide partnership that has received a three-year, $7.9 million funding award from the Patient-Centered Outcomes Research Institute, or PCORI, to support patient-centered health care research throughout Florida and the country. The partnership includes the University of Florida, Florida State University, health care systems, health plans, providers and patients.
Despite routine warnings about the dangers of extreme sun exposure, many parents are not taking appropriate steps to protect their babies. That’s the finding of a small study conducted by skin cancer experts at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.